Bruce Car

Insider Reports History

Entity
Individual
Location
Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, MA
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bruce Car:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Ltd. Chief Scientific Officer Common Shares 30K $1.01M $33.58 Jun 17, 2024 By IRA
AGIOS PHARMACEUTICALS, INC. Chief Scientific Officer Restricted stock units 11.5K $285K $24.79 Mar 1, 2022 Direct
Biohaven Ltd. Chief Scientific Officer Common Shares 2.38K $80K $33.58 Jun 17, 2024 Direct
Biohaven Ltd. Chief Scientific Officer Stock Options (Right to buy) 96.3K Jan 2, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Chief Scientific Officer Stock options (right to buy) 41K Mar 1, 2022 Direct

Insider Reports Filed by Bruce Car

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Ltd. Jun 17, 2024 1 $1.01M 4 Jun 20, 2024 Chief Scientific Officer
BHVN Biohaven Ltd. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Scientific Officer
BHVN Biohaven Ltd. Nov 2, 2023 1 $0 4 Nov 6, 2023 Chief Scientific Officer
BHVN Biohaven Ltd. Oct 3, 2022 1 $0 4 Oct 5, 2022 Chief Scientific Officer
BHVN Biohaven Ltd. Sep 28, 2022 0 $0 3 Oct 5, 2022 Chief Scientific Officer
AGIO AGIOS PHARMACEUTICALS, INC. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Scientific Officer
AGIO AGIOS PHARMACEUTICALS, INC. Feb 18, 2022 3 -$59.4K 4 Feb 23, 2022 Chief Scientific Officer
AGIO AGIOS PHARMACEUTICALS, INC. Feb 10, 2022 3 -$33.7K 4 Feb 14, 2022 Chief Scientific Officer
AGIO AGIOS PHARMACEUTICALS, INC. Jan 6, 2022 3 -$39.3K 4 Jan 10, 2022 Chief Scientific Officer